BRPI0410343A - formas truncadas de dbf4 humana, complexos com seus pares de interação e métodos para identificação de seus inibidores - Google Patents

formas truncadas de dbf4 humana, complexos com seus pares de interação e métodos para identificação de seus inibidores

Info

Publication number
BRPI0410343A
BRPI0410343A BRPI0410343-2A BRPI0410343A BRPI0410343A BR PI0410343 A BRPI0410343 A BR PI0410343A BR PI0410343 A BRPI0410343 A BR PI0410343A BR PI0410343 A BRPI0410343 A BR PI0410343A
Authority
BR
Brazil
Prior art keywords
human
complex
dbf4
truncated forms
inhibitors
Prior art date
Application number
BRPI0410343-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Barbara Valsasina
Cinzia Cristiani
Stefan Knapp
Sandrine Thieffine
Rita Perego
Maria Beatrice Saccardo
Henryk Kalisz
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of BRPI0410343A publication Critical patent/BRPI0410343A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0410343-2A 2003-05-05 2004-04-20 formas truncadas de dbf4 humana, complexos com seus pares de interação e métodos para identificação de seus inibidores BRPI0410343A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46795603P 2003-05-05 2003-05-05
PCT/EP2004/050568 WO2004099243A2 (en) 2003-05-05 2004-04-20 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof

Publications (1)

Publication Number Publication Date
BRPI0410343A true BRPI0410343A (pt) 2006-05-30

Family

ID=33435149

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410343-2A BRPI0410343A (pt) 2003-05-05 2004-04-20 formas truncadas de dbf4 humana, complexos com seus pares de interação e métodos para identificação de seus inibidores

Country Status (4)

Country Link
EP (1) EP1622934A2 (de)
BR (1) BRPI0410343A (de)
CA (1) CA2524528A1 (de)
WO (1) WO2004099243A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10335471B2 (en) 2015-08-28 2019-07-02 Immatics Biotechnologies Gmbh Method for treating cancer with activated T cells
TWI782434B (zh) 2015-08-28 2022-11-01 德商英麥提克生物技術股份有限公司 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架
GB201515321D0 (en) 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003076623A1 (en) * 2002-03-12 2003-09-18 Japan Science And Technology Agency Cdc7-ASK KINASE COMPLEX, SUBSTRATE OF THE KINASE COMPLEX, ANTIBODY SPECIFIC TO THE SUBSTRATE, AND METHOD OF SCREENING COMPOUND CAPABLE OF INHIBITING Cdc7-ASK KINASE USING THE SAME

Also Published As

Publication number Publication date
EP1622934A2 (de) 2006-02-08
WO2004099243A3 (en) 2005-01-20
CA2524528A1 (en) 2004-11-18
WO2004099243A2 (en) 2004-11-18
WO2004099243A8 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
IL257622B (en) Methods and compositions for the treatment of persistent infections
DK1377589T3 (da) Oxazolyl-pyrazolderivater som kinaseinhibitorer
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
ECSP088350A (es) Pirazolopirimidinas como inhibidores de protein quinasas
IL228952A0 (en) Pharmaceutical compositions comprising ferric citrate for reducing serum phosphate levels, and use thereof for the preparation of medicaments for treating or ameliorating calcium-associated disorders
BRPI0410418A (pt) fenil quinolinas e seu uso como moduladores do receptor de estrogênio
WO2004089396A3 (en) Anti-fungal peptidomimetics
DE602005026031D1 (de) Kristalline formen von (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid zur verwendung als aktivstoff in pharmazeutischen zubereitungen
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BRPI0407583A (pt) solução oftálmica lìmpida e estável
TR200102020T2 (tr) Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler.
EP1639141A4 (de) Verfahren zur behandlung von lentivirusinfektionen
DK1327143T3 (da) Krystalstruktur af BACE og anvendelse deraf
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
CY1108540T1 (el) Ταυτοποιηση θεραπευτικων ενωσεων
ATE496892T1 (de) Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
TW200640487A (en) Combination of XOLAIR with immunosuppressive agent
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
CL2004000877A1 (es) Combinacion farmaceutica que comprende 8a) melatonina y agonistas de la melatonina, y nicotina y agonistas receptores de nicotina; kit farmaceutico, y; uso en el tratamiento de insomnio, dificultades cognitivas y dificultades de memoria; kit farmaceu
BRPI0410343A (pt) formas truncadas de dbf4 humana, complexos com seus pares de interação e métodos para identificação de seus inibidores
WO2004083241A3 (en) Btc-interacting proteins and use thereof
DE50213507D1 (de) Verfahren und mittel zur beeinflussung von interzellulärer kommunikation und interzellulärem organellentransport
ATE353642T1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
AR023464A1 (es) Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados
ATE545421T1 (de) Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]